For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Obamacare’s subsidy cliff: How many enrollees are actually affected?
Democrats in Congress have put Obamacare front and center in their opposition to the Republicans’ temporary budget. One provision of the American Rescue Plan…
National Review
RFK Jr.’s Cherry-Picked Science
One of Robert F. Kennedy Jr.’s promises as secretary of health and human services was to bring gold-standard science to our public…
Blog
The TrumpRx medicine will prove worse than the disease
On September 30, President Trump, standing alongside the CEO of Pfizer, announced a multifaceted deal wherein Pfizer would inoculate itself from new regulations and…
Search Posts
Blog
Medicaid cost explosion
Over the past five years, Medicaid has defied all expectations and projections. It is the third largest program that the government administers, and it has…
Blog
Big Beautiful Bill threatens the Costco of health care
You’ve probably never wondered why you buy peanut butter from the grocery store instead of directly from the J.M. Smucker Company or your TV from…
News Release
MAHA Commission recommendations on improving government-directed research merit consideration
President Trump’s Make America Healthy Again Commission released the “Making Our Children Health Again” report, which seeks to evaluate health trends among America’s youth,…
Blog
States can keep Medicaid whole if they want
Congress is considering slowing Medicaid growth over the next 10 years enough to reduce federal spending by $625 billion. Many Republicans argue that the…
The Washington Examiner
Capping drug prices will cripple innovation and harm public health
The Washington Examiner cited CEI’s expert on life-saving drugs and technology The Competitive Enterprise Institute was similarly scathing. “As with many industries, the United States…
Blog
Free the Economy podcast: Reforming Medicaid with Brian Blase
In a recent episode we cover biofuels and farm tariffs, the decline in green investing, and the effort to stop state governments…